At Helico, our goal is to unlock the innate ability of plants to become factories for medicinal compounds. Employing innovative research in computational biology and plant physiology, we've packed advanced manufacturing facilities in seeds to produce the world's most needed medicines.
Helico is designing computational and plant models to bring our partners’ targets through a successful manufacturing process. We provide expertise and services in the following areas:
- Design of molecular production
- Computational biology and bioinformatic
- Plant physiology improvements
- Contract manufacturing of biologics
Do you have a specific project in mind?
Exploring new ways to produce your compound?
Get in touch !
Helico is designing computational and plant models to bring our partners’ targets through a successful manufacturing process. We provide expertise and services in the following areas:
- Design of molecular production
- Computational biology and bioinformatic
- Plant physiology improvements
- Contract manufacturing of biologics
Do you have a specific project in mind?
Exploring new ways to produce your compound?
Get in touch !
Location: New Zealand, Auckland
Employees: 1-10
Total raised: $1.27M
Investors 2
| Date | Name | Website |
| - | Outset Ven... | outset.ven... |
| - | Icehouse V... | icehouseve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.05.2022 | Seed | $1.27M | - |
Mentions in press and media 1
| Date | Title | Description |
| 18.05.2022 | Helico Raises AUD $1.8M in Seed Funding | Helico, an Auckland, New Zealand-based biopharma company, raised AUD $1.8M in Seed funding. The round was led by Icehouse Ventures, with participation from Custos Privatestiftung, and David Ross. The company intends to use the funds to exte... |